Over the past decade, Candida auris has emerged as a worldwide public health threat. Since its first isolation in 2009 in Japan, C. auris infections have been reported in over 30 countries.(1) Together with the increasing number of infections, this fungus is a cause of concern for three main reasons. First, C. auris easily proliferates in hospitals and has the potential to cause outbreaks in healthcare settings. Secondly, it is often resistant to multiple antifungal drugs commonly used to treat Candida infections, such as Fluconazole, and thirdly, it is often challenging to identify with standard laboratory methods.